LACOSAMIDE

Main information

  • Trade name:
  • LACOSAMIDE Film-coated tablet 50MG
  • Dosage:
  • 50MG
  • Pharmaceutical form:
  • Film-coated tablet
  • Administration route:
  • Oral use
  • Units in package:
  • 210 Tablet container
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • LACOSAMIDE Film-coated tablet 50MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • LACOSAMIDE
  • Product summary:
  • LACOSAMIDE

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization number:
  • F - specific therapeutic programme
  • Last update:
  • 17-01-2018

9-9-2011

Danish Pharmacovigilance Update, 18 August 2011

Danish Pharmacovigilance Update, 18 August 2011

Among the topics covered in this issue are Vimpat® 15mg/ml syrup (lacosamide) for treatment of epilepsy, which is recalled due to a quality defect and Nplate® (romiplostim), which could increase the risk of disease progression in patients with myelodysplastic syndrome (MDS).

Danish Medicines Agency

There are no news related to this product.